Resources

In 2024, support for GM technologies largely reflects results shown in 2019. After the global COVID-19 pandemic and spikes in support in 2021, attitudes appear to have returned to a new ‘baseline’. 38% of the Australian community in support of its use in general.

This document provides baseline information about the parent organisms for use in risk assessments of genetically modified B. napus and B. juncea that may be released into the Australian environment.

Use this form to apply for the surrender of a low- or high-level containment facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000.

This document provides a step by step guide on how to access the form to suspend a certification in the OGTR's Online Services Portal.

This document provides a step by step guide on how to access the form to lift a suspension of a certification in the OGTR's Online Services Portal.

This document provides a step by step guide on how to access the form to surrender a certification in the OGTR's Online Services Portal.

Details of OGTR monitoring and compliance activities during the quarter ended 30 September 2023.

Details of OGTR monitoring and compliance activities during the quarter ended 31 December 2023.

Use this form to provide or update contact details for key personnel for organisations and Institutional Biosafety Committees (IBCs), or to change user access to the OGTR Online Services Portal.

Details of OGTR monitoring and compliance activities during the quarter ended 30 June 2024.

Misinformation has been circulating regarding mRNA COVID-19 vaccines and gene therapy. The following statement addresses this misinformation.

This Communique covers matters considered at the 38th videoconference of the Gene Technology Technical Advisory Committee (17 June 2024).

Use this form to apply for accreditation of an organisation under the Gene Technology Act 2000 and any applicable state legislation.

This application is for the certification of a facility to a specified containment level in accordance with Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000 and any applicable state legislation.

This fact sheet aims to clarify what level of notification and advance warning is required for low-level (PC1 and PC2, excluding PC2 Large Scale) certified facilities that undergo maintenance work.

Use this form to apply for a suspension of a low- or high-level containment facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000.

Use this form to apply for the lift of suspension of a low or high-level containment facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000.

Use this form to apply for the variation of a facility currently certified under the Guidelines for the Certification of Physical Containment Facilities issued under the Gene Technology Act 2000 and, as applicable, corresponding state legislation.

Use this form to notify the OGTR of commencement or completion of minor works to PC1 or PC2 certified facilities.

Complete this application if you have unintentionally obtained a GMO or did not know an organism was a GMO when you obtained it.

This issue focuses on the PC2 Guidelines and the OGTR Online Services Portal.

This Communique covers matters considered at the 20th meeting of the Gene Technology Ethics and Community Consultative Committee (10 May 2024).

This guide provides assistance from the point of logging into the OGTR Online Services Portal. It follows from the OGTR Online Services Registration Guide.